# High-throughput methods enabling random duplications, deletions, or nucleotide-constrained mutagenesis of entire DNA motifs

**Authors:** Marcus Wäneskog, Knud Nor Nielsen, Marcus Deichmann, Samuel Alan Bradley, Michael Krogh Jensen, Emil Damgaard Jensen

PMC · DOI: 10.1093/nar/gkag236 · 2026-03-24

## TL;DR

The paper introduces two new DNA mutagenesis methods that allow precise and random modifications of DNA sequences for genetic engineering and functional studies.

## Contribution

Two novel DNA mutagenesis methods (RADDIM and NSM) enable precise random duplications, deletions, and constrained mutagenesis of DNA motifs.

## Key findings

- RADDIM allows random duplication, deletion, or insertion of DNA motifs in yeast promoters to alter transcription.
- NSM enables nucleotide-constrained mutagenesis of DNA regions to restore β-lactamase function via in-frame InDels.
- The methods allow bespoke mutagenesis for functional mapping of regulatory DNA and protein structures.

## Abstract

Currently available random and untargeted DNA mutagenesis techniques are limited by both the number of consecutive nucleotides that can be mutated and by the type of accessible mutations. These methodologies also create multiple different mutated sites within each DNA sequence-of-interest, which significantly confounds any precise and high-throughput phenotype-to-genotype mapping. Here, we describe two unique and cell-independent DNA mutagenesis methods that enable either a single random and small-scale (1–30 nt) duplication, deletion, or insertion of an entire DNA motif (RADDIM), or nucleotide-constrained mutagenesis of random DNA regions spanning >8 consecutive nucleotides (NSM). By utilizing these mechanistically unique methods, we randomly duplicated and deleted cryptic regulatory DNA elements in two yeast promoters (pACT1 and pTEF1) to change their transcriptional expression. We randomly mutated the protein structure of an inactivated β-lactamase (TEM-1) to restore its enzymatic function by generating multiple, consecutive in-frame InDels. We also selectively mutated the AT-content and introduced TATA-box–like sequences and homopolymeric mutations, within random DNA regions. Collectively, RADDIM and NSM allow for an unprecedented level of bespoke DNA mutagenesis at random DNA locations, expanding the toolkit for genetic engineering, directed evolution, and the functional mapping of novel protein structures and cryptic regulatory DNA motifs.

Graphical Abstract

## Linked entities

- **Genes:** Pact1 (platelet activation 1) [NCBI Gene 109401], CD248 (CD248 molecule) [NCBI Gene 57124]

## Full-text entities

- **Genes:** TEM1 (Ras family GTPase TEM1) [NCBI Gene 854938], TEM-1 beta-lactamase [NCBI Gene 13905334], TEM-1 [NCBI Gene 2716540], Flap Endonuclease 1 [NCBI Gene 24867788], SLX1 (endonuclease) [NCBI Gene 852529], CcdB toxin [NCBI Gene 20493255], CcdB [NCBI Gene 6276084], ACT1 (actin) [NCBI Gene 850504] {aka ABY1, END7}
- **Diseases:** NSM (MESH:C566309), toxicity (MESH:D064420)
- **Chemicals:** dGTP (MESH:C029603), manganese (MESH:D008345), dATP (MESH:C026600), 2'-Deoxyribavirin-5'-O-triphosphate (-), agarose (MESH:D012685), chloramphenicol (MESH:D002701), KCl (MESH:D011189), 8-Oxo-dGTP (MESH:C078206), acid (MESH:D000143), ampicillin (MESH:D000667), MgCl2 (MESH:D015636), MnCl2 (MESH:C025340), EDTA (MESH:D004492), beta-lactam (MESH:D047090), agar (MESH:D000362), Nb (MESH:D009556), dCTP (MESH:C024107), histidine (MESH:D006639), ATP (MESH:D000255), AT (MESH:D001246), dTTP (MESH:C024157), water (MESH:D014867), nucleotide (MESH:D009711), NaCl (MESH:D012965), glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606], Sulfolobus (genus) [taxon 2284], Thermococcus (genus) [taxon 2263], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Escherichia coli (E. coli, species) [taxon 562]
- **Mutations:** proline at position 40, AW42ins, G-to-T, C782T, A40P, T539C, A-to-G, C118G, RVG44ins, A452G, T121C, C118A, P40R, D33E, E210A, A629C, R41W, 124ins, T235C, C-to-A, C for 10-30, T261M, 122ins, P40T, P40A, G-to-A, G537A, CS41ins, C118T, 120ins, tryptophan at position 41, W41del, A-to-C, A281C, E277fs, T-to-A, W41R, C-to-T, C with 200, T-to-G, 128ins, 829ins, A-to-T, P40S, G291A, M180T, H151R, T121A
- **Cell lines:** TOP10 — Homo sapiens (Human), Chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_TT29), SH800S — Homo sapiens (Human), Finite cell line (CVCL_1V10)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13010153/full.md

---
Source: https://tomesphere.com/paper/PMC13010153